Original Research
Accepted on 14 May 2025
Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): A 12-month longitudinal study
in Vaccines and Molecular Therapeutics